Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TP-102 bacteriophage therapy in diabetic foot infection
NCT05948592Phase 2Completed
- Sponsor
- TechnoPhage
- Start
- Nov 2023
- Primary completion
- Oct 2025
- Modality
- Single Strain Products, Multi-strain Products
- Countries
- 2
01
Overview
A Phase 2 trial of TP-102 in diabetic foot infection (DFI), sponsored by TechnoPhage. Started Nov 2023; status: completed.
02
Drugs
TP-102
03
Conditions
diabetic foot infection (DFI)
Beyond the preview
Go deeper on NCT05948592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05948592.